[Differential indications for uricosuric drugs and allopurinol].

Suppr

超能文献

作者信息

Gröbner W, Zöllner N

机构信息

Krankenanstalten des Zollernalbkreises, Innere Abteilung, Kreiskrankenhaus, Balingen.

出版信息

Klin Wochenschr. 1989 Mar 1;67(5):313-5. doi: 10.1007/BF01892902.

DOI:10.1007/BF01892902

PMID:2709742

Abstract

摘要

相似文献

[Differential indications for uricosuric drugs and allopurinol].

Klin Wochenschr. 1989 Mar 1;67(5):313-5. doi: 10.1007/BF01892902.

[Drug therapy of hyperuricemia].

Verh Dtsch Ges Inn Med. 1986;92:492-7.

Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.

Med Lett Drugs Ther. 2017 Nov 6;59(1533):182-183.

Editorial: Drugs used in hyperuricaemia.

S Afr Med J. 1974 Jun 22;48(30):1278.

Drugs in the treatment of hyperuricemia.

Adv Nephrol Necker Hosp. 1974;3:51-7.

[Therapeutic agents for gout effecting the kidney].

Geka Chiryo. 1970 Mar;22(3):317-22.

The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.

Australas Ann Med. 1967 Aug;16(3):205-14. doi: 10.1111/imj.1967.16.3.205.

Recent developments in the therapy of gout.

J Am Geriatr Soc. 1968 May;16(5):499-504. doi: 10.1111/j.1532-5415.1968.tb02088.x.

The treatment of hyperuricemia in gout.

Ration Drug Ther. 1974 Mar;8(3):1-4.

[Treatment of gout].

Geka Chiryo. 1970 Mar;22(3):311-6.

引用本文的文献

Uricosuric effect of irtemazole in healthy subjects.

Klin Wochenschr. 1989 Oct 2;67(19):971-5. doi: 10.1007/BF01716059.

Uricosuric effect of different doses of irtemazole in normouricaemic subjects.

Eur J Clin Pharmacol. 1990;38(5):489-91. doi: 10.1007/BF02336689.

Uric acid levels in southern Germany in 1989. A comparison with studies from 1962, 1971, and 1984.

Klin Wochenschr. 1990 Dec 17;68(24):1222-8. doi: 10.1007/BF01796514.

本文引用的文献

Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.

Eur J Clin Pharmacol. 1982;22(1):77-84. doi: 10.1007/BF00606429.

[Influence of benzbromarone on the pharmacokinetics and pharmacodynamics of oxipurinol].

Arzneimittelforschung. 1982;32(9):1149-52.

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Am J Med. 1984 Jan;76(1):47-56. doi: 10.1016/0002-9343(84)90743-5.

[Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].

Arzneimittelforschung. 1983;33(12):1687-91.

Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?

Klin Wochenschr. 1984 Dec 17;62(24):1170-2. doi: 10.1007/BF01712184.

Enzymatic and metabolic studies with allopurinol.

Ann Rheum Dis. 1966 Nov;25(6 Suppl):608-14. doi: 10.1136/ard.25.Suppl_6.608.

[Effect of benzbromaronum on the renal uric acid excretion in healthy persons].

Klin Wochenschr. 1970 Apr 1;48(7):426-32. doi: 10.1007/BF01487010.

Radioisotope studies of purine metabolism during administration of guanine and allopurinol in the pig.

Biochem Pharmacol. 1973 Oct 15;22(20):2553-63.

The development of allopurinol.

Arch Intern Med. 1985 Aug;145(8):1492-503.

Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.

Eur J Clin Pharmacol. 1986;31(1):53-8. doi: 10.1007/BF00870986.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验